ArticleBMC ophthalmology2026
Barriers to immediate corticosteroid treatment in suspected giant cell arteritis with visual symptoms: insights from a tertiary eye care unit.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVisual symptoms in Giant cell arteritis (GCA) represent a sight-threatening condition; immediate treatment with systemic corticosteroids is important. Treatment delays may occur due to several issues such as diagnostic uncertainty, unfamiliarity with managing the condition or logistical medication issues. Current literature has not assessed local factors that might impact timely management of suspected GCA patients with visual features; we explored this and created an innovative infographic to enhance current practice.
methodsFollowing an index case, we formed a multi-disciplinary working group to improve current practice. We started with an online questionnaire assessing the confidence and practice of our emergency eye care (EEC) team managing suspected GCA patients presenting with visual symptoms. Responses were collected over 4 weeks.
resultsWe obtained valid responses from 41 out of 53 EEC staff. Most respondents felt confident taking a history (mean self-rating 4.3/5, CI: 4.0-4.6) and knowing investigations for GCA with visual loss (mean 4.0/5, CI: 3.7–4.3). However, participants were less confident liaising with rheumatology colleagues out of hours (mean 2.7/5, CI: 2.2–3.2). While 37.5% (n = 15) of respondents thought they knew the pharmacy team’s working hours, only one person was able to specify these correctly. We used information from the survey to design a novel GCA infographic, incorporating British Society of Rheumatology (BSR) 2020 and European Alliance of Associations for Rheumatology (EULAR) 2018 guidelines. We displayed the infographic in EEC and provided teaching to EEC staff to address the issues that we found.
conclusionsThis novel study has identified local factors that negatively impact immediate management of suspected GCA patients in EEC and designed an infographic to support clinical decision-making. Data from other centres and further evaluation of this approach is needed to assess its impact on practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.